DVS Sciences Citing Rise in Publications, Piper Jaffray Projects Solid Growth for Fluidigm CyTOF in 2015 According to the Piper Jaffray analysis, of the 54 total papers published using CyTOF technology, 25 of them, or 46 percent, were published in 2014. Fluidigm Q3 Revenues Grow 62 Percent NEW YORK (GenomeWeb) — Fluidigm said after the close of the market on Thursday that its third quarter revenues increased 62 percent year over year, or 35 percent organically. Fluidigm Q1 Revenues Rise 77 Percent on Instrument Sales NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Monday that its first quarter revenues increased 77 percent year over year, driven by strong instrument sales as well as contributions from a recent acquisition. Stanford, Zurich Teams Develop Mass Spec-based Proteomics Technologies for Targeted Tissue Imaging Premium Two research teams have separately developed new imaging mass spec technologies for targeted protein measurements in tissue. Fluidigm Continues Move into Proteomics with $207.5M Acquisition of DVS Sciences Premium Fluidigm said this week that it has agreed to acquire mass cytometry firm DVS Sciences for roughly $207.5 million in company common stock and cash. Jan 29, 2014 Fluidigm to Purchase Mass Cytometry Firm DVS Sciences for $207M in Cash and Stock Sep 6, 2013 DTU Team Testing Orbitrap Fusion's Phosphoproteomic Capabilities as Part of Thermo Collaboration Premium May 10, 2013 New Products: DVS Sciences, Biognosys Premium Apr 26, 2013 Stanford Researchers Applying Multi-omics Approach to Profiling Immune Health Premium Jan 11, 2013 German Startup Zellkraftwerk Launches Chip Cytometry Service; Aims to Release Instrument this Fall Premium Aug 24, 2012 Nolan Lab Profiles Small-Molecule Inhibitors Using New Multiplexing Method for DVS Sciences' CyTOF Premium Jul 2, 2012 DVS Sciences, Cytobank Partner on Data Software for Mass Cytometry Jun 29, 2012 DVS Sciences Collaborating with Cytobank on Informatics Tools for CyTOF Platform Premium Dec 9, 2011 People in the News: Joseph Victor; Leroy Hood; and More Premium Jul 15, 2011 Pfizer, Roche Join $14.6M Financing for Mass Cytometry Startup DVS Sciences Premium Jul 14, 2011 DVS Sciences Raises $14.6M May 13, 2011 Stanford Team Uses DVS Sciences' CyTOF for Massive Hematopoietic Cell Protein Signaling Project Premium Mar 4, 2011 Q&A: University of Toronto's Scott Tanner on the Use of Atomic Mass Spectrometry in Proteomics Premium May 21, 2010 Univ. of Toronto Spinout Rolls Out New Biomarker System with Eye on Bead Array Market Apr 26, 2010 OICR Invests in Personalized Medicine Spin-offs Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.